Tackling human problems through biotechnology.

Michelle McMurry-Heath brings a wide-ranging background in medicine, immunology, research, and policy coordination to her current role as the chief executive officer for the Biotechnology Innovation Organization (BIO). She had a chat with Cell editor Cheri Sirois about how biotech differs from basic science and about the opportunities it offers.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 She had a chat with Cell editor Cheri Sirois about how biotech differs from basic science and about the opportunities it offers.
• 2 A lightly edited transcript of their conversation is shared here.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: